09:59 Oct 18
Alembic Pharmaceuticals Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Alembic Pharmaceuticals Ltd.
97/100 High Financial Strength
Quality37/100 Mid Valuation
Valuation58/100 Technically Neutral
TechnicalSWOT
Strength
7
Weakness
2
Opportunity
0
Threat
0
22.68K
Market Cap (Cr)
36.01
PE Ratio
4.84
Price to Book Ratio
50.96
RSI
9.88 %
Net Profit Margin
Rating Based on 3 Analysts
Buy
0%
Hold
100%
Sell
0%
Hold
Analyst Price Target
The average price target is 1017.33 with a high estimate of 1122 and low estimate of 960
Current 1154.00
Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation
SWOT
Download Our App On:
